Saturday October 2nd

07h30
Welcoming coffee

------------------------------------------------------------------------------------

SESSION I
Moderators: Nicos Labropoulos & Jess Lindholt
-------------------------------------------------------

08h00 The vulnerable abdominal aorta in man, wall mechanics and stress regulation in response to age/sex and diabetes: implications for aneurysmal disease?
Toste Länne, Linköping, Sweden

08h20  Biomechanics of AAA
Tim McGloughlin, Limerick, Ireland


08h40
Prognosis of aortic aneurysms followed by PET-CT
Natzi Sakalihasan, Liège, Belgium

08h55  Potential strategies for medical management of aortic aneurysms
Jonathan Golledge, Townsville, Australia

09h10  Antiplatelet therapy to inhibit AAA growth based upon two cohorts
Jess S. Lindholt, Viborg, Denmark


09h25  Short presentations

Falling incidence of abdominal aortic aneurysms in Australia
Norman Paul, Crawley, Australia


Regional differences in wall deformation and mechanics in descending aorta by Velocity Vector Imaging
Petrini Johan, Stockholm, Sweden

Analysis of Cardiovascular Risk Factors in Patients with Diabetes and Abdominal Aortic Aneurysm (AAA)
Sohrabi Soroush, Leeds, United Kingdom


Relationship between cardiovascular risk factors, atherosclerosis burden and diameter of abdominal aorta: A prospective study
Depairon Michele, Lausanne, Switzerland

Do statins affect Abdominal Aortic Aneurysm (AAA) growth rates? A systematic review of the literature
Bailey Marc, Leeds, United Kingdom

09h50  Discussion

10h05  Coffee break

 

SESSION II
Moderators: Hendrik Van Damme & Frank Vermassen
---------------------------------------------------------

10h35  Laparoscopic repair of aorto-occlusive diseases
Janine Quaniers, Liège, Belgium


10h50   Management of abdominal aortic aneurysms and coexistent diseases
Vladislav Treska, Pilsen, Czech Republic


11h05   Endovascular treatment for aorto-enteric fistula and aorto-caval communication
Athanasios Giannoukas, Larissa, Greece


11h20   Endoleak detection with duplex scanning after EVAR
Nicos Labropoulos, New York, USA


11h35   A novel hybrid device for the treatment of aortic aneurysm
Koichi Yoshimura, Ube, Japan


11h50   Short presentations

The renal sequelae of endovascular abdominal aortic aneurysm (AAA) repair (EVAR) revisited
Bailey Marc, Leeds, United Kingdom


Calcium Channel Blockers enhance sac shrinkage following Endovascular Abdominal Aortic Aneurysm Repair (EVAR)
Bailey Marc, Leeds, United Kingdom
  

Carotid artery and ischemic heart disease have a bimodal association with aortic diameter
Jones Gregory, Dunedin, New Zealand


EVAR and gender differences in the female population with aortic aneurysm
Alan Lossing, Toronto, Canada

12h10  Discussion

12h30  Lunch

13h30  Poster presentations
Moderators: Nicos Labropoulos & Vladislav Treska

Aneurysms of the diaphragmatic aortic segment following previous aortic surgery: institutional experience
Sebesta Pavel, Prague, Czech Republic


The effects of increasing obesity on outcomes after endovascular repair of abdominal aortic aneurism
Pollice Francesco, Andria, Italy


Initial Clinical Experience with the Ovation™ Abdominal Stent Graft System for Endovascular Repair of Abdominal Aortic Aneurysm
Nolte Thomas, Bad Bevensen, Germany


Analysis of Cardiovascular Risk factors in Male and Female patients with Abdominal Aortic Aneurysm (AAA)
Sohrabi Soroush, Leeds, United Kingdom

SESSION III
Moderators: Eric Allaire et Eric Steinmetz
------------------------------------

14h30  Risk management of AAA: which horse to bet on?
Arnoud Meijer, Leiden, The Netherlands


14h45  Long term outcome after AAA repair: a french database
Eric Steinmetz, Dijon, France


15h00 Ruptured abdominal aortic aneurysms: status quo after a quarter century of treatment experience
Wilhelm Sandmann, Kamp-Lintfort, Germany


15h15 Place of the EVAR in ruptured AAA
Janet Powell, London, United Kingdom


15h30 Short presentations

Mortality, morbidity, and costs of ruptured and elective abdominal aortic aneurysm
Pollice Francesco, Andria, Italy

15h35   Discussion

16h00  Coffee break

----------------------------------------------------------------------------------------------------

---------------------------------------------------------------------------------------------------

16h30 Long term results of DREAM: time to wake up?
Jan D. Blankensteijn, Amsterdam, The Netherlands

16h50 Results of OVER trials
Frank Lederle, Mineapolis, MN, USA


17h10 Ten year results of EVAR 1 & 2 trials
Janet Powell, London, United Kingdom

17h30 Early results of ACE trials
Jean Marzelle, Créteil, France


17h50 Discussion

18h10 Prizes and closing remarks
Helena Kuivaniemi, Danville, USA
Janet Powell, London, United Kingdom